Monoclonal antibodies against sars-cov-2 nucleocapsid phosphoprotein and sandwich elisa method
AssigneeThe Trustees of Columbia University in the City of New York
InventorsDavid D. HO, Lihong LIU
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Trustees of Columbia University in the City of New York
InventorsDavid D. HO, Lihong LIU
Estimating the term…
Disclosed herein is a kit for detecting or quantifying a SARS-CoV-2 nucleocapsid phosphoprotein, including a first antibody, wherein a variable heavy chain domain comprises the amino acid sequence selected from the group consisting of SEQ ID NOs: 1, 3, 5, 7, 11, 13, 15, 17, 19, and 21, and a variable light chain domain comprises the amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 12, 14, 16, 18, 20, and 22; and a second antibody, wherein a variable heavy chain domain comprises the amino acid sequence selected from the group consisting of SEQ ID NOs: 9 and 13, and a variable light chain domain comprises the amino acid sequence selected from the group consisting of SEQ ID NOs: 10 and 14.
A kit for detecting or quantifying a SARS-CoV-2 nucleocapsid phosphoprotein, the kit comprising:
23-54. (canceled)
Dependencies are inferred from the claim text.